Clinical Trial Update: CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating CC-4047 (pomalidomide) in combination with gemcitabine for untreated advanced pancreatic cancer has completed, and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-03-13